ArticlePharmacoEconomics - open2025

Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?

Waranya Rattanavipapong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.